Clinical trial

Semaglutide Treatment for Hyperglycaemia After Renal Transplantation

NCT05702931

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-09-19

PhasePHASE4

Study timeline

Study start (actual)2024-09-19Date precision: day

Registry last updated2025-12-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hyperglycemiaunresolved

Renal Transplant Complication Primary Non-Functionunresolved

Diabetesunresolved

Interventions

Semaglutide 14 MG [Rybelsus]DRUG · verified · RxNorm: semaglutide 14 MG [Rybelsus]

Sponsors & collaborators

Copenhagen University Hospital, Rigshospitaletlead sponsor

Aarhus University Hospitalcollaborator

Odense University Hospitalcollaborator

Mapped research locations

CopenhagenDenmark1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05702931 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.